Equities Analysts Offer Predictions for MDGL FY2024 Earnings
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Free Report) – Leerink Partnrs upped their FY2024 earnings per share (EPS) estimates for shares of Madrigal Pharmaceuticals in a research report issued on Wednesday, February 5th. Leerink Partnrs analyst T. Smith now anticipates that the biopharmaceutical company will post earnings per share of ($22.71) for the year, up from […]
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Free Report) – Leerink Partnrs upped their FY2024 earnings per share (EPS) estimates for shares of Madrigal Pharmaceuticals in a research report issued on Wednesday, February 5th. Leerink Partnrs analyst T. Smith now anticipates that the biopharmaceutical company will post earnings per share of ($22.71) for the year, up from […]
